Chamaejasmenin B exhibits significant potential in pharmaceutical applications due to its biological activities. It has demonstrated cytotoxic effects against certain cancer cell lines, suggesting a role in anticancer drug development. Studies indicate it may induce apoptosis and inhibit cell proliferation, particularly in tumor cells. Additionally, it shows antimicrobial properties, making it a candidate for use in treating microbial infections. Its anti-inflammatory effects further support its therapeutic relevance, possibly contributing to treatments for inflammatory diseases. Research is ongoing to explore its efficacy, safety, and mechanisms of action for future clinical use.